Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ImmunoGen Selects Cytovance To Manufacture Antibody | Contract Pharma

What are you searching for?

Sign in
Breaking News

ImmunoGen Selects Cytovance To Manufacture Antibody

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ImmunoGen, Inc. has selected Cytovance Biologics for process development, cell banking and cGMP manufacturing of a proprietary ImmunoGen antibody.
   
Cytovance will use its 44,000-sq.-ft., multi-product cGMP production facility in Oklahoma City, OK for the project. Cytovance specializes in the production of clinical antibody and recombinant protein products derived from cell culture at scales as high as 500L (w/v) from both fed-batch and perfusion processes.
   
“We are very pleased to partner with ImmunoGen and provide manufacturing excellence to their products,” said Darren Head president and chief executive officer of Cytovance. “Our relationship with ImmunoGen is an excellent example of our business model, value, services and state-of-the-art facilities.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics